Hosted on MSN2d
Johnson & Johnson Just Paid Investors: Here’s How Much They Received
Key Points Johnson & Johnson (NYSE: JNJ) just rewarded its shareholders again with a quarterly dividend. As a Dividend King, ...
Johnson & Johnson snaps six days of losing streak
Johnson & Johnson (NYSE:JNJ) shares traded in the green on Monday, snapping six consecutive days of losses. The stock closed ...
Johnson & Johnson stock underperforms Tuesday when compared to competitors
Johnson & Johnson closed $19.62 below its 52-week high ($168.85), which the company achieved on September 4th.
Institutional investors may adopt severe steps after Johnson & Johnson's (NYSE:JNJ) latest 3.5% drop adds to a year losses
Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable ...
STAT2d
Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma
Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...
Seeking Alpha13d
How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding
Johnson & Johnson’s high EBIT Margin [TTM] of 26.40% is not only an indicator of the company’s financial health, but also demonstrates its positioning within the Pharmaceuticals Industry.
Seeking Alpha29d
Johnson & Johnson: Tracking Well Above The Industry
As a result, Icontinue to cover Johnson & Johnson with a 'Buy' rating. Equally important, the New Brunswick, New Jersey-based company, led by its CEO Joaquin Duato, was able to make significant ...
cbn.co.za1d
Johnson & Johnson marks new era as global healthcare company with updated visual identity
Janssen adopts J&J name as part of global rebranding initiative Renaming will unite the medical technology and pharmaceutical ...
Johnson & Johnson stock underperforms Wednesday when compared to competitors
This was the stock's fourth consecutive day of losses.